These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36320594)

  • 1. Therapeutic Bacteriophages for Gram-Negative Bacterial Infections in Animals and Humans.
    Zagaliotis P; Michalik-Provasek J; Gill JJ; Walsh TJ
    Pathog Immun; 2022; 7(2):1-45. PubMed ID: 36320594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel
    Khan FM; Gondil VS; Li C; Jiang M; Li J; Yu J; Wei H; Yang H
    Front Cell Infect Microbiol; 2021; 11():637313. PubMed ID: 33738267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel antimicrobial agents for combating antibiotic-resistant bacteria.
    Chang RYK; Nang SC; Chan HK; Li J
    Adv Drug Deliv Rev; 2022 Aug; 187():114378. PubMed ID: 35671882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bactericidal Effect of Cecropin A Fused Endolysin on Drug-Resistant Gram-Negative Pathogens.
    Lim J; Hong J; Jung Y; Ha J; Kim H; Myung H; Song M
    J Microbiol Biotechnol; 2022 Jun; 32(6):816-823. PubMed ID: 35586934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review.
    Mulani MS; Kamble EE; Kumkar SN; Tawre MS; Pardesi KR
    Front Microbiol; 2019; 10():539. PubMed ID: 30988669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Susceptibilities of multidrug-resistant pathogens responsible for complicated skin and soft tissue infections to standard bacteriophage cocktails].
    Gündoğdu A; Kılıç H; Ulu Kılıç A; Kutateladze M
    Mikrobiyol Bul; 2016 Apr; 50(2):215-23. PubMed ID: 27175494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriophages for ESKAPE: role in pathogenicity and measures of control.
    Patil A; Banerji R; Kanojiya P; Koratkar S; Saroj S
    Expert Rev Anti Infect Ther; 2021 Jul; 19(7):845-865. PubMed ID: 33261536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Analysis of distribution and drug resistance of pathogens from the wounds of 1 310 thermal burn patients].
    Zhang C; Gong YL; Luo XQ; Liu MX; Peng YZ
    Zhonghua Shao Shang Za Zhi; 2018 Nov; 34(11):802-808. PubMed ID: 30481922
    [No Abstract]   [Full Text] [Related]  

  • 9. The endolysin of the Acinetobacter baumannii phage vB_AbaP_D2 shows broad antibacterial activity.
    Yuan Y; Li X; Wang L; Li G; Cong C; Li R; Cui H; Murtaza B; Xu Y
    Microb Biotechnol; 2021 Mar; 14(2):403-418. PubMed ID: 32519416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic Signatures from Adaptation of Bacteria to Lytic Phage Identify Potential Agents To Aid Phage Killing of Multidrug-Resistant Acinetobacter baumannii.
    Oyejobi GK; Xiong D; Shi M; Zhang X; Yang H; Xue H; Ogolla F; Wei H
    J Bacteriol; 2022 Mar; 204(3):e0059321. PubMed ID: 35156836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting Pathogenic Bacteria on Two Fronts: Phages and Antibiotics as Combined Strategy.
    Tagliaferri TL; Jansen M; Horz HP
    Front Cell Infect Microbiol; 2019; 9():22. PubMed ID: 30834237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacteriophage therapeutics to confront multidrug-resistant Acinetobacter baumannii - a global health menace.
    Rai S; Kumar A
    Environ Microbiol Rep; 2022 Jun; 14(3):347-364. PubMed ID: 34196126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial.
    Giammanco A; Calà C; Fasciana T; Dowzicky MJ
    mSphere; 2017; 2(1):. PubMed ID: 28124025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gram-Negative Bacterial Lysins.
    Ghose C; Euler CW
    Antibiotics (Basel); 2020 Feb; 9(2):. PubMed ID: 32054067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. On-Demand Isolation of Bacteriophages Against Drug-Resistant Bacteria for Personalized Phage Therapy.
    Mattila S; Ruotsalainen P; Jalasvuori M
    Front Microbiol; 2015; 6():1271. PubMed ID: 26617601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections.
    Pallavali RR; Degati VL; Lomada D; Reddy MC; Durbaka VRP
    PLoS One; 2017; 12(7):e0179245. PubMed ID: 28719657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies to combat Gram-negative bacterial resistance to conventional antibacterial drugs: a review.
    Bhowmik P; Modi B; Roy P; Chowdhury A
    Osong Public Health Res Perspect; 2023 Oct; 14(5):333-346. PubMed ID: 37920891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of distribution and drug resistance of pathogens of burn patients during 9 years].
    Dou Y; Zhang Q
    Zhonghua Shao Shang Za Zhi; 2018 Mar; 34(3):153-159. PubMed ID: 29609277
    [No Abstract]   [Full Text] [Related]  

  • 19. Predominance of Gram-negative bacilli and increasing antimicrobial resistance in nosocomial bloodstream infections at a university hospital in southern Taiwan, 1996-2003.
    Wu CJ; Lee HC; Lee NY; Shih HI; Ko NY; Wang LR; Ko WC
    J Microbiol Immunol Infect; 2006 Apr; 39(2):135-43. PubMed ID: 16604246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity.
    Kim S; Jin JS; Choi YJ; Kim J
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33238548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.